Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Bridging psychosocial care after cancer treatment

Official title: Bridging the Gap in Psychosocial Care for Cancer Survivors: Integrating Digital Screening With Navigation Call

Run by University Hospital, Basel, Switzerland · NCT07672314 · Data updated 2026-11-12

This study tests a routine digital distress screen plus a psycho-oncology navigation call to help cancer survivors access support after completing treatment.

More Psychological Distress trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedJune 26, 2026
Main results expectedMay 2028
Study endsMay 2028
Registry record updatedAugust 10, 2026
Trial IDNCT07672314 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who have completed primary cancer treatment and are attending follow-up at University Hospital Basel, able to provide informed consent and sufficient German language skills.

Probably not a fit

Patients with severe cognitive impairment, acute psychiatric symptoms, primary brain tumors, or those unable to participate in the navigation call may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This one-centre feasibility study examines whether adding a digital psychosocial screening together with a structured navigation call is acceptable and practical for cancer survivors after primary treatment. The approach aims to identify unmet psychosocial needs and reduce barriers to care by guiding patients to appropriate support services. Researchers will look at how feasible and acceptable the intervention is, how it affects psychosocial burden and service use, and why participants choose to accept or decline psychosocial care. The study will recruit adults under care at University Hospital Basel who have completed primary treatment and can provide informed consent, with several exclusion criteria to ensure safety and language requirements are met.

Why it matters

Potential benefit: If feasible and acceptable, this approach could improve timely identification and access to psychosocial support for survivors.

How similar studies have gone: Prior research supports routine distress screening, but combining digital screening with a targeted navigation call for survivors is a novel approach in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged ≥18 years
* Under oncological care at the USB for ≥9 months
* Completion of primary cancer treatment (see definition below)
* Attendance at routine oncological follow-up at USB
* Ability to provide written informed consent

Exclusion Criteria:

* Primary brain tumors
* Severe cognitive impairment
* Acute psychiatric symptoms that may impair the participant's ability to provide informed consent or comply with study procedures
* Insufficient German language skills

Where it's running

  • University Hospital Basel
    Basel, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.